Replimune Group, Inc. (REPL)

4.60 -0.31 (-6.31%) USD  |  NASDAQ  |  May 26, 16:00
4.62 +0.02 (+0.43%) After-Hours: 07:09
More

Replimune Group Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
REGENXBIO, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Spyre Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
ANI Pharmaceuticals, Inc. Upgrade